Mediterranean Fish Vaccine Market Trends and Analysis by 2030
Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type (Inactivated Vaccine, Live-attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccine), Route of Administration (Immersion Vaccine, Injection Vaccine, and Oral Vaccine), Species (Turbot, European Anchovy and Seabass, Salmon, Mediterranean Sea Bass, Common Dentex and Common Pandora, Sea Bream, Rainbow Wrasse, Sparus Aurata, Trout, Mediterranean Swordfish and Bluefin Tuna, Grouper and Amberjack, and Others), and Country
- Status : Published
- Report Code : TIPRE00030007
- Category : Life Sciences
- No. of Pages : 199
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type, Route of Administration, Species, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Driving factors such as government initiatives to develop the Mediterranean aquaculture industry and the surging demand for aquatic animal-derived food products propel market growth. However, strict regulatory policies for the approval of vaccines hinder market growth.
The Mediterranean fish vaccine market is analyzed based on the key countries that have good aquaculture industries, which include France, Italy, Spain, Egypt, Greece, Turkey, Israel, and the Rest of the Mediterranean.
Zoetis Inc; Merck & Co Inc; HIPRA SA; ICTYODEV SAS; Acuipharma Aquaculture Health SL; Phibro Animal Health Corp; Vaxxinova International BV; Kyoto Biken Laboratories Inc; Elanco Animal Health Inc, and Ceva SA are the major companies operating in the market.
The “Mediterranean Fish Vaccine Market” is segmented on the basis of vaccine type, species, route of administration, clinical indication, and country. Based on the vaccine type, the market is bifurcated into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. Based on species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean sea bass, common dentex and common pandora, sea bream, rainbow wrasse, Sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack, and others. In terms of route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. And based on clinical indication, the market is classified as bacterial infection and viral infection.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Mediterranean Fish Vaccine Market – Market Landscape
4.1 Overview
4.1.1 Mediterranean Region PEST Analysis
4.2 Mediterranean Fish Species
4.3 List of Mediterranean Fish Species
5. Mediterranean Fish Vaccine Market – Regional Analysis
5.1 Key Market Drivers:
5.1.1 Government Initiatives to Develop Mediterranean Aquaculture Industry
5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Key Market Restraints:
5.2.1 Strict Regulatory Policies for Approval of Vaccines
5.3 Key Market Opportunities:
5.3.1 Development of Novel Vaccines
5.4 Future Trends:
5.4.1 Shift from Conventional Vaccines to DNA Vaccines
5.5 Impact Analysis:
6. Mediterranean Fish Vaccine Market – Regional Analysis
6.1 Mediterranean Fish Vaccine Market Revenue Forecast and Analysis
7. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
7.1 Overview
7.2 Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
7.3 Inactivated Vaccine
7.3.1 Overview
7.3.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Live Attenuated Vaccine
7.4.1 Overview
7.4.2 Live Attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Toxoid Vaccine
7.5.1 Overview
7.5.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Subunit Vaccine
7.6.1 Overview
7.6.2 Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Conjugate Vaccine
7.7.1 Overview
7.7.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Recombinant Vector Vaccine
7.8.1 Overview
7.8.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Immersion Vaccine
8.3.1 Overview
8.3.2 Immersion Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Injection Vaccine
8.4.1 Overview
8.4.2 Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Species.
9.1 Overview
9.2 Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
9.3 Turbot
9.3.1 Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.4 European Anchovy and Seabass
9.4.1 European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Salmon
9.5.1 Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Mediterranean Sea Bass
9.6.1 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Common Dentex and Common Pandora
9.7.1 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Sea Bream
9.8.1 Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Rainbow Wrasse
9.9.1 Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.10 Sparus aurata
9.10.1 Sparus aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.11 Trout
9.11.1 Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.12 Mediterranean Swordfish and Bluefin Tuna
9.12.1 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.13 Grouper and Amberjack
9.13.1 Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.14 Others
9.14.1 Others: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
10. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Clinical Indication
10.1 Overview
10.2 Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
10.3 Bacterial Infection
10.3.1 Overview
10.3.2 Bacterial Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Viral Infection
10.4.1 Overview
10.4.2 Viral Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
11. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 Mediterranean Fish Vaccine Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.2 Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.2 Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.3 Mediterranean Fish Vaccine Market, by Species
11.1.2.4 Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.4.1 Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.4.2 Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5 Mediterranean Fish Vaccine Market by Country
11.1.2.5.1 France
11.1.2.5.1.1 Overview
11.1.2.5.1.2 France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.1.2.1 France: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.1.2.2 France: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.1.2.3 France: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.1.2.4 France: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.1.2.4.1 France: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.1.2.4.2 France: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.2 Italy
11.1.2.5.2.1 Overview
11.1.2.5.2.2 Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.2.2.1 Italy: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.2.2.2 Italy: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.2.2.3 Italy: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.2.2.4 Italy: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.2.2.4.1 Italy: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.2.2.4.2 Italy: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.3 Spain
11.1.2.5.3.1 Overview
11.1.2.5.3.2 Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.3.2.1 Spain: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.3.2.2 Spain: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.3.2.3 Spain: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.3.2.4 Spain: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.3.2.4.1 Spain: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.3.2.4.2 Spain: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.4 Egypt
11.1.2.5.4.1 Overview
11.1.2.5.4.2 Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.4.2.1 Egypt: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.4.2.2 Egypt: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.4.2.3 Egypt: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.4.2.4 Egypt: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.4.2.4.1 Egypt: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.4.2.4.2 Egypt: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.5 Israel
11.1.2.5.5.1 Overview
11.1.2.5.5.2 Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.5.2.1 Israel: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.5.2.2 Israel: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.5.2.3 Israel: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.5.2.4 Israel: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.5.2.4.1 Israel: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.5.2.4.2 Israel: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.6 Turkey
11.1.2.5.6.1 Overview
11.1.2.5.6.2 Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.6.2.1 Turkey: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.6.2.2 Turkey: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.6.2.3 Turkey: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.6.2.4 Turkey: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.6.2.4.1 Turkey: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.6.2.4.2 Turkey: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.7 Greece
11.1.2.5.7.1 Overview
11.1.2.5.7.2 Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.7.2.1 Greece: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.7.2.2 Greece: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.7.2.3 Greece: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.7.2.4 Greece: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.7.2.4.1 Greece: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.7.2.4.2 Greece: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.8 Rest of the Mediterranean
11.1.2.5.8.1 Overview
11.1.2.5.8.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.8.2.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.8.2.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.8.2.3 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.8.2.4 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.8.2.4.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.8.2.4.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Viral Infection
12. Pre and Post COVID-19 Impact
12.1 Pre and Post COVID-19 Impact
13. Mediterranean Fist Vaccine Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in Mediterranean Fish Vaccine Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Zoetis Inc
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck & Co Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 HIPRA SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 ICTYODEV SAS
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 ACUIPHARMA AQUACULTURE HEALTH SL
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Phibro Animal Health Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Vaxxinova International BV
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Kyoto Biken Laboratories Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Elanco Animal Health Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Ceva SA
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. Mediterranean Fish Vaccine Market Segmentation
Table 2. Species of Fishes, Disease and Available Vaccine –
Table 3. Bacterial Pathogens of Fishes –
Table 4. USDA Approved Bacterial Fish Vaccines –
Table 5. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 6. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 7. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Species
Table 8. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Clinical Indication
Table 9. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Bacterial Infection
Table 10. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Viral Infection
Table 11. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 12. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 13. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 14. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 15. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 16. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 17. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 18. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 19. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 20. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 21. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 22. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 23. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 24. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 25. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 26. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 27. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 28. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 29. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 30. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 31. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 32. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 33. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 34. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 35. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 36. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 37. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 38. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 39. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 42. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 43. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 44. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 45. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 46. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 47. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 48. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 49. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 50. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 51. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 52. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 53. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 54. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 55. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) –Species
Table 56. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) –Clinical Indication
Table 57. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 58. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 59. Recent Inorganic Growth Strategies in the Mediterranean Fish Vaccine Market
Table 60. Recent Organic Growth Strategies in Mediterranean fish vaccine Market
Table 61. Glossary of Terms
List of Figures
Figure 1. Mediterranean Fish Vaccine Market Segmentation, By Region
Figure 2. Mediterranean Region: PEST Analysis
Figure 3. Mediterranean Fish Vaccine Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Mediterranean Fish Vaccine Market – Revenue Forecast and Analysis – 2020–2030
Figure 6. Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
Figure 7. Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Live Attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
Figure 18. Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Sparus aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
Figure 31. Bacterial Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Viral Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Mediterranean Fish Vaccine Market, By Region, 2022 ($Mn)
Figure 34. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mediterranean Fish Vaccine Market, By Key Countries, 2022 And 2030 (%)
Figure 36. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Pre and Post COVID-19 Impact on Mediterranean Fish Vaccine Market
Figure 45. Growth Strategies in Mediterranean Fish Vaccine Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For